P. Brissot and O. Loreal, Iron metabolism and related genetic diseases: A cleared land, keeping mysteries, J Hepatol, vol.64, issue.2, pp.505-520, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01231421

P. Brissot, A. Pietrangelo, P. C. Adams, B. De-graaff, C. E. Mclaren et al., Nat Rev Dis Primers, vol.4, p.18016, 2018.

O. Loreal, T. Cavey, F. Robin, M. Kenawi, P. Guggenbuhl et al., Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects, Pharmaceuticals (Basel), vol.11, issue.4, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01976757

C. Moreau, J. A. Duce, O. Rascol, J. C. Devedjian, D. Berg et al., Iron as a therapeutic target for Parkinson's disease, Mov Disord, vol.33, issue.4, pp.568-74, 2018.

S. Tury, F. Assayag, F. Bonin, S. Chateau-joubert, J. L. Servely et al., The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers, J Pathol, vol.246, issue.1, pp.103-117, 2018.